Study of duralabhadi vati in management of pittaj mutrakrucchra with special reference to urinary tract infectio
Phase 1
- Conditions
- Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classifiedHealth Condition 2: N390- Urinary tract infection, site notspecified
- Registration Number
- CTRI/2020/02/023416
- Lead Sponsor
- Annasaheb Dange Ayurved Medical College Ashta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient with clinical signs and symptoms of pittaj mutrakrucchra described in Ayurvedic text book
Age 18 to 60 year both sex patients selected
Urine pus cell up to 8/high power field
RBCS in urine up to 8/high power field
Exclusion Criteria
Diagnosed patient of pregnancy
Diagnosed patient of benign prostatic hyperplasia
Diagnosed patient of malignancy of any part of urinary tract
Phimosis and paraphimosis
Traumatic causes.
Renal failure
Diagnosed urinary tract infection associated with calculus.
Diagnosed patient of diabetes mellitus.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the effect of Duralabhadi vati in the management of pittaj <br/ ><br>mutrakrucchraTimepoint: 24 weeks
- Secondary Outcome Measures
Name Time Method To study mode of action of duralabhadi vatiTimepoint: 20 weeks